Ad is loading...
AYBLX
Price
$11.28
Change
-$0.11 (-0.97%)
Updated
Nov 15 closing price
RLEFX
Price
$36.11
Change
-$0.33 (-0.91%)
Updated
Nov 15 closing price
Ad is loading...

AYBLX vs RLEFX

Header iconAYBLX vs RLEFX Comparison
Open Charts AYBLX vs RLEFXBanner chart's image
Pioneer Balanced ESG Y
Price$11.28
Change-$0.11 (-0.97%)
VolumeN/A
CapitalizationN/A
American Funds American Balanced R5E
Price$36.11
Change-$0.33 (-0.91%)
VolumeN/A
CapitalizationN/A
AYBLX vs RLEFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
AYBLX vs. RLEFX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AYBLX is a StrongBuy and RLEFX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RLEFX has more cash in the bank: 236B vs. AYBLX (423M). RLEFX pays higher dividends than AYBLX: RLEFX (2.42) vs AYBLX (2.11). AYBLX was incepted earlier than RLEFX: AYBLX (33 years) vs RLEFX (9 years). RLEFX is a more actively managed with annual turnover of: 171.00 vs. AYBLX (44.00). RLEFX has a lower initial minimum investment than AYBLX: RLEFX (250) vs AYBLX (5000000). RLEFX annual gain was more profitable for investors over the last year : 21.09 vs. AYBLX (16.86). RLEFX return over 5 years is better than : 35.95 vs. AYBLX (25.51).
AYBLXRLEFXAYBLX / RLEFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence33 years9 years-
Gain YTD10.45014.21174%
Front LoadN/AN/A-
Min. Initial Investment50000002502,000,000%
Min. Initial Investment IRAN/AN/A-
Net Assets423M236B0%
Annual Yield % from dividends2.112.4287%
Returns for 1 year16.8621.0980%
Returns for 3 years1.7310.9516%
Returns for 5 years25.5135.9571%
Returns for 10 years33.85N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SKYW111.330.52
+0.47%
SkyWest
TCBK47.59-0.02
-0.04%
TriCo Bancshares
WIT6.72-0.07
-1.03%
Wipro Limited
EDAP2.45-0.07
-2.78%
EDAP TMS SA
ELEV0.53-0.05
-8.41%
Elevation Oncology